Back

Personalized permanent pacing guided by hemodynamic study as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Device therapy (1) Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Valeria Rella

Italian Auxological Institute San Luca Hospital, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Safety and effectiveness of adapted definitive pacemakers to perform temporary cardiac stimulation - The TEMPACE multicenter study
Doctor R. Vicente Miralles (Alicante, ES)
Abstract Slides Video
Presentation thumbnail
Prospective evaluation of carbon dioxide as a contrast medium in pacemakers or defibrillators carriers for venous angiography (SPARKLING pilot study)
Doctor A. Spadotto (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Temporal analysis of stimulation parameters evolution in the left bundle branch area pacing
Doctor A. Reyes Garcia (Jaen, ES)
Abstract Slides Video
Presentation thumbnail
Efficacy of drug eluting envelopes in reducing infections among pacemaker patients: the REINFORCE real-world data project
Doctor M. Ziacchi (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Device therapy (1)

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Left bundle branch pacing. what you should not do
thumbnail
Congress Session
Late-Breaking Clinical Science: spectrum of cardiomyopathies
thumbnail
Congress Session
Hypertrophic cardiomyopathy: from gene to treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources